Theoretical Construction, Clinical Application and Advantages of Traditional Chinese Medicine in the Treatment of Central Serous Chorioretinopathy Based on Zangfu and Meridian Syndrome Differentiation: A Review
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v6i4.4818
Abstract
Central serous chorioretinopathy (CSC) is a kind of macular disease, which mainly occurs in young and middle-aged men. It is characterized by serous detachment of retinal neuroepithelium or pigment epithelium caused by choroidal capillary leakage. The disease is self-limited to some extent, but recurrent episodes can lead to irreversible visual impairment.According to traditional Chinese medicine (TCM), this disease belongs to the category of "Zhizhan Yiyao", and its occurrence is closely related to the dysfunction of liver, spleen and kidney and the adverse vaporization of trijiao. This article systematically reviews the TCM diagnosis and treatment system based on Professor Chen Dafu's "six meridian-syndrome differentiation in ophthalmology", and expounds its theoretical construction, clinical application characteristics and advantages of integrated traditional Chinese and western medicine in the staged treatment of CSC, in order to provide reference for clinical practice.
Keywords
central serous chorioretinopathy; zangfu syndrome differentiation; meridian syndrome differentiation; six meridians syndrome differentiation; five rounds and eight section
Full Text
PDF - Viewed/Downloaded: 2 TimesReferences
[1] XU Yuqiu, ZHOU Wei, Qiao Lingyu, et al. To explore from the foot lunar spleen through differentiation central serous retinopathy [J]. Chinese journal of ophthalmology of traditional Chinese medicine, 2021, 31 (11): 811-814. The DOI: 10.13444/j.carol carroll nki zgzyykzz. 2021.11.010.
[2] ZHOU T. Discussion on Professor Wei Wei's treatment of central serous chorioretinopathy from Zangfu differentiation based on medication rules [J]. Clinical Research of Traditional Chinese Medicine, 2020,17(14):8-13.
[3] Liu Yang, Yang Jia-wei, ZHU Si-quan. Analyses from the treatment of liver and spleen and kidney central serous retinopathy [J]. Chinese journal of ophthalmology of traditional Chinese medicine, 2021, 31 (3): 192-194. The DOI: 10.13444/j.carol carroll nki zgzyykzz. 2021.03.008.
[4] WU Jianguo, WEI Dong, Chu Liqun, et al. Analyses from the "six depression" differentiation central serous retinopathy [J]. Chinese journal of ophthalmology of traditional Chinese medicine, 2022, 32 (7): 553-558. The DOI: 10.13444/j.carol carroll nki zgzyykzz. 2022.07.010.
[5] Zhu Yixing, Feng Yanbing, Deng Chao, et al. WengWenQing staging experience in treating central serous retinopathy [J]. Journal of traditional Chinese medicine, zhejiang 2022,57 (7): 482. DOI: 10.13633/j.carol carroll nki ZJTCM. 2022.07.005.
[6] Suo Lijuan, Song Yan-min, WANG Dalong, et al. [12] Clinical study of mouse nerve growth factor combined with electroacupuncture in the treatment of optic atrophy [J]. Guizhou Medicine,2020,44(11):1693-1695.
[7] Shang Yulin, Zhang Maoju. [13] ZHANG M J. Progress of traditional Chinese medicine treatment of central serous chorioretinopathy [J]. Chinese Traditional Medicine Modern Distance Education,2020,18(17):148-150. (in Chinese with English abstract)
[8] Zhao Mengmeng, Jin LAN, Song Yan-min, et al. Immovable therapy of traditional Chinese medicine treatment of dry eyes of 75 patients [J]. Journal of shaanxi university of traditional Chinese medicine, 2019, and (4): 77-80 + 90. DOI: 10.13424/j.carol carroll nki JSCTCM. 2019.04.020.
[2] ZHOU T. Discussion on Professor Wei Wei's treatment of central serous chorioretinopathy from Zangfu differentiation based on medication rules [J]. Clinical Research of Traditional Chinese Medicine, 2020,17(14):8-13.
[3] Liu Yang, Yang Jia-wei, ZHU Si-quan. Analyses from the treatment of liver and spleen and kidney central serous retinopathy [J]. Chinese journal of ophthalmology of traditional Chinese medicine, 2021, 31 (3): 192-194. The DOI: 10.13444/j.carol carroll nki zgzyykzz. 2021.03.008.
[4] WU Jianguo, WEI Dong, Chu Liqun, et al. Analyses from the "six depression" differentiation central serous retinopathy [J]. Chinese journal of ophthalmology of traditional Chinese medicine, 2022, 32 (7): 553-558. The DOI: 10.13444/j.carol carroll nki zgzyykzz. 2022.07.010.
[5] Zhu Yixing, Feng Yanbing, Deng Chao, et al. WengWenQing staging experience in treating central serous retinopathy [J]. Journal of traditional Chinese medicine, zhejiang 2022,57 (7): 482. DOI: 10.13633/j.carol carroll nki ZJTCM. 2022.07.005.
[6] Suo Lijuan, Song Yan-min, WANG Dalong, et al. [12] Clinical study of mouse nerve growth factor combined with electroacupuncture in the treatment of optic atrophy [J]. Guizhou Medicine,2020,44(11):1693-1695.
[7] Shang Yulin, Zhang Maoju. [13] ZHANG M J. Progress of traditional Chinese medicine treatment of central serous chorioretinopathy [J]. Chinese Traditional Medicine Modern Distance Education,2020,18(17):148-150. (in Chinese with English abstract)
[8] Zhao Mengmeng, Jin LAN, Song Yan-min, et al. Immovable therapy of traditional Chinese medicine treatment of dry eyes of 75 patients [J]. Journal of shaanxi university of traditional Chinese medicine, 2019, and (4): 77-80 + 90. DOI: 10.13424/j.carol carroll nki JSCTCM. 2019.04.020.
Copyright © 2026 Bo Zhang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License